Galmed Pharmaceuticals logo

Galmed Pharmaceuticals (GLMD) Q1 2024 Earnings

GLMD·Reported May 30, 2024·Before market open

Diluted EPS came in at $-2.76.

Diluted EPS
$-2.76
SEC

SEC Filings

Earnings release8-K not filed yet
Quarterly report10-Q / 10-K not filed yet

Filings will appear here once submitted to SEC EDGAR.

Q1 2024 Earnings FAQ

Common questions about Galmed Pharmaceuticals's Q1 2024 earnings report.

Galmed Pharmaceuticals (GLMD) reported Q1 2024 earnings on May 30, 2024 before market open.

Galmed Pharmaceuticals reported diluted EPS of $-2.76 for Q1 2024.